This report provides a comprehensive analysis of the global Swine Streptococcus Vaccine market, examining its growth trajectory from 2025 through 2032. It evaluates critical segments including vaccine types, such as live and inactivated, and applications across piglets and adult pigs. The study explores key regional dynamics in the Americas, APAC, and Europe while profiling major industry players like MSD Animal Health and Zoetis. Ultimately, the research highlights market drivers, competitive strategies, and emerging opportunities within this vital animal health sector.

Market Overview

The global Swine Streptococcus Vaccine market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate over the forecast period.

Disease Context and Importance

Streptococcus suis is a common bacterial infectious disease affecting pigs, which can occasionally lead to outbreaks and cause severe mortality in swine populations. Vaccines are utilized for the prevention of swine septicemia streptococcus disease caused by the Streptococcus zooepidemicus group C.

Regional Market Analysis

Global Outlook

The global Swine Streptococcus Vaccine market is expected to undergo substantial expansion between 2025 and 2032, maintaining a consistent growth trajectory.

United States

The United States market for Swine Streptococcus Vaccine is estimated to increase significantly from 2025 through 2032, growing at a sustained compound annual growth rate.

China

The China market for Swine Streptococcus Vaccine is estimated to undergo continuous growth from 2025 to 2032, characterized by a steady compound annual growth rate.

Europe

The Europe market for Swine Streptococcus Vaccine is estimated to expand throughout the forecast period from 2025 to 2032, showing a consistent compound annual growth rate.

Market Segmentation

By Type

• Live Vaccine
• Inactivated Vaccine

By Application

• Piglets
• Adult Pigs

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Market Dynamics

In terms of revenue, the global market is characterized by significant concentration, with the two largest companies occupying a substantial portion of the market share in 2025. This Insight Report highlights key trends related to product segmentation, company formation, revenue, market share, latest developments, and M&A activity. It also analyzes the strategies of leading global companies, focusing on their Swine Streptococcus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints to understand their unique positions in an accelerating market.

Key Vendors

The following companies have been profiled based on primary expert input and analysis of their coverage, product portfolios, and market penetration:

• MSD Animal Health
• Boehringer-Ingelheim
• Hipra
• Merck Animal Health
• Zoetis Animal Health
• Ceva Animal Health
• Native Antigen
• SPAH
• Nanjing Tianbang Biological Technology
• Sichuan Huapai Bio-pharmaceutical
• Guangdong Winsun Bio Pharmaceutical
• Wuhan Keqian Biology
• Shanghai Hile Bio-Technology
• Harbin Pharmaceutical Group Bio-Vaccine
• Ringpu
• China Animal Husbandry Industry

About the Report

LP Information, Inc. (LPI)'s newest research report, the “Swine Streptococcus Vaccine Industry Forecast,” reviews total world Swine Streptococcus Vaccine sales in 2025 and examines past sales data. The report provides a comprehensive analysis by region and market sector of projected Swine Streptococcus Vaccine sales for 2026 through 2032. With sales broken down by region, market sector, and sub-sector, the report offers a detailed analysis in US$ millions of the global industry.

This study evaluates key market trends, drivers, and affecting factors shaping the global outlook. By utilizing a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, the report breaks down the forecast by Type, Application, geography, and market size to highlight emerging pockets of opportunity and provide a nuanced view of the current state and future trajectory of the industry.

Key Questions Addressed

• What is the 10-year outlook for the global Swine Streptococcus Vaccine market?
• What factors are driving Swine Streptococcus Vaccine market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Swine Streptococcus Vaccine market opportunities vary by end market size?
• How does Swine Streptococcus Vaccine break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Swine Streptococcus Vaccine Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Swine Streptococcus Vaccine by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Swine Streptococcus Vaccine by Country/Region, 2021, 2025 & 2032

  • 2.2 Swine Streptococcus Vaccine Segment by Type

    • 2.2.1 Live Vaccine

    • 2.2.2 Inactivated Vaccine

    • 2.2.3 Swine Streptococcus Vaccine Sales by Type

      • 2.2.3.1 Global Swine Streptococcus Vaccine Sales Market Share by Type (2021-2026)
      • 2.2.3.2 Global Swine Streptococcus Vaccine Revenue and Market Share by Type (2021-2026)
      • 2.2.3.3 Global Swine Streptococcus Vaccine Sale Price by Type (2021-2026)

  • 2.3 Swine Streptococcus Vaccine Segment by Application

    • 2.3.1 Piglets

    • 2.3.2 Adults Pigs

    • 2.3.3 Swine Streptococcus Vaccine Sales by Application

      • 2.3.3.1 Global Swine Streptococcus Vaccine Sale Market Share by Application (2021-2026)
      • 2.3.3.2 Global Swine Streptococcus Vaccine Revenue and Market Share by Application (2021-2026)
      • 2.3.3.3 Global Swine Streptococcus Vaccine Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Swine Streptococcus Vaccine Breakdown Data by Company

    • 3.1.1 Global Swine Streptococcus Vaccine Annual Sales by Company (2021-2026)

    • 3.1.2 Global Swine Streptococcus Vaccine Sales Market Share by Company (2021-2026)

  • 3.2 Global Swine Streptococcus Vaccine Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Swine Streptococcus Vaccine Revenue by Company (2021-2026)

    • 3.2.2 Global Swine Streptococcus Vaccine Revenue Market Share by Company (2021-2026)

  • 3.3 Global Swine Streptococcus Vaccine Sale Price by Company

  • 3.4 Key Manufacturers Swine Streptococcus Vaccine Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Swine Streptococcus Vaccine Product Location Distribution

    • 3.4.2 Players Swine Streptococcus Vaccine Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Swine Streptococcus Vaccine by Geographic Region

  • 4.1 World Historic Swine Streptococcus Vaccine Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Swine Streptococcus Vaccine Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Swine Streptococcus Vaccine Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Swine Streptococcus Vaccine Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Swine Streptococcus Vaccine Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Swine Streptococcus Vaccine Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Swine Streptococcus Vaccine Sales Growth

  • 4.4 APAC Swine Streptococcus Vaccine Sales Growth

  • 4.5 Europe Swine Streptococcus Vaccine Sales Growth

  • 4.6 Middle East & Africa Swine Streptococcus Vaccine Sales Growth

• 5 Americas

  • 5.1 Americas Swine Streptococcus Vaccine Sales by Country

    • 5.1.1 Americas Swine Streptococcus Vaccine Sales by Country (2021-2026)

    • 5.1.2 Americas Swine Streptococcus Vaccine Revenue by Country (2021-2026)

  • 5.2 Americas Swine Streptococcus Vaccine Sales by Type (2021-2026)

  • 5.3 Americas Swine Streptococcus Vaccine Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Swine Streptococcus Vaccine Sales by Region

    • 6.1.1 APAC Swine Streptococcus Vaccine Sales by Region (2021-2026)

    • 6.1.2 APAC Swine Streptococcus Vaccine Revenue by Region (2021-2026)

  • 6.2 APAC Swine Streptococcus Vaccine Sales by Type (2021-2026)

  • 6.3 APAC Swine Streptococcus Vaccine Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Swine Streptococcus Vaccine by Country

    • 7.1.1 Europe Swine Streptococcus Vaccine Sales by Country (2021-2026)

    • 7.1.2 Europe Swine Streptococcus Vaccine Revenue by Country (2021-2026)

  • 7.2 Europe Swine Streptococcus Vaccine Sales by Type (2021-2026)

  • 7.3 Europe Swine Streptococcus Vaccine Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Swine Streptococcus Vaccine by Country

    • 8.1.1 Middle East & Africa Swine Streptococcus Vaccine Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Swine Streptococcus Vaccine Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Swine Streptococcus Vaccine Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Swine Streptococcus Vaccine Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Swine Streptococcus Vaccine

  • 10.3 Manufacturing Process Analysis of Swine Streptococcus Vaccine

  • 10.4 Industry Chain Structure of Swine Streptococcus Vaccine

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Swine Streptococcus Vaccine Distributors

  • 11.3 Swine Streptococcus Vaccine Customer

• 12 World Forecast Review for Swine Streptococcus Vaccine by Geographic Region

  • 12.1 Global Swine Streptococcus Vaccine Market Size Forecast by Region

    • 12.1.1 Global Swine Streptococcus Vaccine Forecast by Region (2027-2032)

    • 12.1.2 Global Swine Streptococcus Vaccine Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Swine Streptococcus Vaccine Forecast by Type (2027-2032)

  • 12.7 Global Swine Streptococcus Vaccine Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 MSD Animal Health

    • 13.1.1 MSD Animal Health Company Information

    • 13.1.2 MSD Animal Health Swine Streptococcus Vaccine Product Portfolios and Specifications

    • 13.1.3 MSD Animal Health Swine Streptococcus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 MSD Animal Health Main Business Overview

    • 13.1.5 MSD Animal Health Latest Developments

  • 13.2 Boehringer-Ingelheim

    • 13.2.1 Boehringer-Ingelheim Company Information

    • 13.2.2 Boehringer-Ingelheim Swine Streptococcus Vaccine Product Portfolios and Specifications

    • 13.2.3 Boehringer-Ingelheim Swine Streptococcus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Boehringer-Ingelheim Main Business Overview

    • 13.2.5 Boehringer-Ingelheim Latest Developments

  • 13.3 Hipra

    • 13.3.1 Hipra Company Information

    • 13.3.2 Hipra Swine Streptococcus Vaccine Product Portfolios and Specifications

    • 13.3.3 Hipra Swine Streptococcus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Hipra Main Business Overview

    • 13.3.5 Hipra Latest Developments

  • 13.4 Merck Animal Health

    • 13.4.1 Merck Animal Health Company Information

    • 13.4.2 Merck Animal Health Swine Streptococcus Vaccine Product Portfolios and Specifications

    • 13.4.3 Merck Animal Health Swine Streptococcus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Merck Animal Health Main Business Overview

    • 13.4.5 Merck Animal Health Latest Developments

  • 13.5 Zoetis Animal Health

    • 13.5.1 Zoetis Animal Health Company Information

    • 13.5.2 Zoetis Animal Health Swine Streptococcus Vaccine Product Portfolios and Specifications

    • 13.5.3 Zoetis Animal Health Swine Streptococcus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Zoetis Animal Health Main Business Overview

    • 13.5.5 Zoetis Animal Health Latest Developments

  • 13.6 Ceva Animal Health

    • 13.6.1 Ceva Animal Health Company Information

    • 13.6.2 Ceva Animal Health Swine Streptococcus Vaccine Product Portfolios and Specifications

    • 13.6.3 Ceva Animal Health Swine Streptococcus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Ceva Animal Health Main Business Overview

    • 13.6.5 Ceva Animal Health Latest Developments

  • 13.7 Native Antigen

    • 13.7.1 Native Antigen Company Information

    • 13.7.2 Native Antigen Swine Streptococcus Vaccine Product Portfolios and Specifications

    • 13.7.3 Native Antigen Swine Streptococcus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Native Antigen Main Business Overview

    • 13.7.5 Native Antigen Latest Developments

  • 13.8 SPAH

    • 13.8.1 SPAH Company Information

    • 13.8.2 SPAH Swine Streptococcus Vaccine Product Portfolios and Specifications

    • 13.8.3 SPAH Swine Streptococcus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 SPAH Main Business Overview

    • 13.8.5 SPAH Latest Developments

  • 13.9 Nanjing Tianbang Biological Technology

    • 13.9.1 Nanjing Tianbang Biological Technology Company Information

    • 13.9.2 Nanjing Tianbang Biological Technology Swine Streptococcus Vaccine Product Portfolios and Specifications

    • 13.9.3 Nanjing Tianbang Biological Technology Swine Streptococcus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Nanjing Tianbang Biological Technology Main Business Overview

    • 13.9.5 Nanjing Tianbang Biological Technology Latest Developments

  • 13.10 Sichuan Huapai Bio-pharmaceutical

    • 13.10.1 Sichuan Huapai Bio-pharmaceutical Company Information

    • 13.10.2 Sichuan Huapai Bio-pharmaceutical Swine Streptococcus Vaccine Product Portfolios and Specifications

    • 13.10.3 Sichuan Huapai Bio-pharmaceutical Swine Streptococcus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.10.4 Sichuan Huapai Bio-pharmaceutical Main Business Overview

    • 13.10.5 Sichuan Huapai Bio-pharmaceutical Latest Developments

  • 13.11 Guangdong Winsun Bio Pharmaceutical

    • 13.11.1 Guangdong Winsun Bio Pharmaceutical Company Information

    • 13.11.2 Guangdong Winsun Bio Pharmaceutical Swine Streptococcus Vaccine Product Portfolios and Specifications

    • 13.11.3 Guangdong Winsun Bio Pharmaceutical Swine Streptococcus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.11.4 Guangdong Winsun Bio Pharmaceutical Main Business Overview

    • 13.11.5 Guangdong Winsun Bio Pharmaceutical Latest Developments

  • 13.12 Wuhan Keqian Biology

    • 13.12.1 Wuhan Keqian Biology Company Information

    • 13.12.2 Wuhan Keqian Biology Swine Streptococcus Vaccine Product Portfolios and Specifications

    • 13.12.3 Wuhan Keqian Biology Swine Streptococcus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.12.4 Wuhan Keqian Biology Main Business Overview

    • 13.12.5 Wuhan Keqian Biology Latest Developments

  • 13.13 Shanghai Hile Bio-Technology

    • 13.13.1 Shanghai Hile Bio-Technology Company Information

    • 13.13.2 Shanghai Hile Bio-Technology Swine Streptococcus Vaccine Product Portfolios and Specifications

    • 13.13.3 Shanghai Hile Bio-Technology Swine Streptococcus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.13.4 Shanghai Hile Bio-Technology Main Business Overview

    • 13.13.5 Shanghai Hile Bio-Technology Latest Developments

  • 13.14 Harbin Pharmaceutical Group Bio-Vaccine

    • 13.14.1 Harbin Pharmaceutical Group Bio-Vaccine Company Information

    • 13.14.2 Harbin Pharmaceutical Group Bio-Vaccine Swine Streptococcus Vaccine Product Portfolios and Specifications

    • 13.14.3 Harbin Pharmaceutical Group Bio-Vaccine Swine Streptococcus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.14.4 Harbin Pharmaceutical Group Bio-Vaccine Main Business Overview

    • 13.14.5 Harbin Pharmaceutical Group Bio-Vaccine Latest Developments

  • 13.15 Ringpu

    • 13.15.1 Ringpu Company Information

    • 13.15.2 Ringpu Swine Streptococcus Vaccine Product Portfolios and Specifications

    • 13.15.3 Ringpu Swine Streptococcus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.15.4 Ringpu Main Business Overview

    • 13.15.5 Ringpu Latest Developments

  • 13.16 China Animal Husbandry Industry

    • 13.16.1 China Animal Husbandry Industry Company Information

    • 13.16.2 China Animal Husbandry Industry Swine Streptococcus Vaccine Product Portfolios and Specifications

    • 13.16.3 China Animal Husbandry Industry Swine Streptococcus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.16.4 China Animal Husbandry Industry Main Business Overview

    • 13.16.5 China Animal Husbandry Industry Latest Developments

• 14 Research Findings and Conclusion